Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational screening of camostat and related compounds against human TMPRSS2: A potential treatment of COVID-19
Tanuj Sharma, Mohammad Hassan Baig, Mohd Imran Khan, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 3, pp. 217-224
Open Access | Times Cited: 12

Showing 12 citing articles:

Identification of apigenin-4’-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies
Manoharan Harini, K. Kavitha, Vadivel Prabakaran, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 1
Closed Access | Times Cited: 6
TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
Gilmara Barros de Lima, Everton Nencioni, Fábio Thimoteo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 75-75
Open Access
Targeting Monoamine Oxidase B for the Treatment of Alzheimer’s and Parkinson’s Diseases Using Novel Inhibitors Identified Using an Integrated Approach of Machine Learning and Computer-Aided Drug Design
Arif Jamal Siddiqui, Sadaf Jahan, Maqsood A. Siddiqui, et al.
Mathematics (2023) Vol. 11, Iss. 6, pp. 1464-1464
Open Access | Times Cited: 7
Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment
Amita Verma, Pradeep Kumar, Irine Pauly, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 46, pp. 3677-3705
Closed Access | Times Cited: 9
Identifying novel and potent inhibitors of EGFR protein for the drug development against the breast cancer
Arif Jamal Siddiqui, Sadaf Jahan, Mitesh Patel, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 14460-14472
Closed Access | Times Cited: 4
Identifying novel inhibitors targeting Exportin-1 for the potential treatment of COVID-19
Tanuj Sharma, Tanmoy Mondal, Sajid Khan, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 2
Closed Access | Times Cited: 1
In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
Shuo Wang, Xuexun Fang, Ye Wang
Molecules (2022) Vol. 27, Iss. 13, pp. 4210-4210
Open Access | Times Cited: 7
Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening
Haviani Rizka Nurcahyaningtyas, Alfrina Irene, Joko Tri Wibowo, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 9, pp. 104984-104984
Open Access | Times Cited: 3
A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies
Barbara Farkaš, Marco Minneci, Matas Misevicius, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 834-834
Open Access | Times Cited: 2
A Present Update of Camostate and the Role in SARS-CoV-2 Infection
Stefan Bittmann
Journal Of Clinical Pediatrics Research (2022)
Open Access | Times Cited: 1
REVIEW: NATURAL BIOACTIVE COMPOUNDS POTENTIAL ON INHIBITION OF TRANSMEMBRANE SERINE PROTEASE 2 WITH STRUCTURE-BASED VIRTUAL SCREENING METHOD
Haviani Rizka Nurcahyaningtyas, Masteria Yunovilsa Putra, Arry Yanuar
Deleted Journal (2023) Vol. 8, Iss. 3, pp. 1089-1100
Open Access
Identifying TMPRSS2 Inhibitors by Drug Repurposing Screenings of Known fXIa Inhibitors: A Computational Study
Yan-Shu Liang, Zhixia Qiao, Fancui Meng
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 590-601
Closed Access
Page 1

Scroll to top